Related Experiment Videos

[Management of persistent ductus arteriosus in the newborn with respiratory insufficiency]

Archivos Del Instituto De Cardiologia De Mexico
|July 1, 1979
PubMed

Insights

For newborns with severe respiratory distress and patent ductus arteriosus, indomethacin is recommended initially. If ineffective within 36 hours, surgical closure is advised to prevent deterioration.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Critical Care

Context:

  • Severe respiratory distress and patent ductus arteriosus (PDA) with congestive heart failure are critical conditions in newborns.
  • Management often involves medical and ventilatory support, but closure of PDA is crucial.

Purpose:

  • To evaluate the efficacy of indomethacin versus surgical closure for PDA in neonates with severe respiratory distress and heart failure.
  • To establish an optimal management strategy for this vulnerable patient population.

Summary:

  • Sixteen neonates with severe respiratory distress and PDA-related heart failure were studied.
  • Indomethacin achieved clinical closure in 5 of 13 cases (38%), while 10 underwent surgical closure with 30% mortality.
  • The study suggests initial indomethacin treatment followed by surgery if unresponsive within 36 hours.

Impact:

  • This approach may improve outcomes by providing a timely, less invasive treatment option.
  • Early intervention with indomethacin could potentially reduce mortality and morbidity associated with PDA in critically ill neonates.

Related Concept Videos